Please login to the form below

Not currently logged in
Email:
Password:

Andrew Lansley becomes Health Secretary

Andrew Lansley has been appointed as Secretary of State for Health, under the Conservative-Liberal Democrat coalition government

Andrew Lansley has been appointed to the role of Secretary of State for Health, under David Cameron's newly formed Conservative-Liberal Democrat coalition government.

 Andrew Lansley, secretary of state for health
Andrew Lansley, Secretary of State for Health
(Picture: Conservative party)


Lansley held the position of Shadow Secretary of State for Health since 2003 under the Conservative's then party leader, Michael Howard. In 2008, he was named the eighth most influential person in the Health Service Journal (HSJ)'s report: 'Fifty People with the Greatest Influence on Today's NHS Policy and Practice'.

Lansley will take over the post from outgoing Health Secretary Andy Burnham, who was appointed to the position in June 2009.

The Conservatives and Liberal Democrats have published a coalition agreement document outlining agreements reached between the two parties on a range of issues. With regards to health, the coalition state: "The parties agree that funding for the NHS should increase in real terms in each year of the Parliament, while recognising the impact this decision would have on other departments." A more detailed document is expected to follow.

12th May 2010

From: Healthcare

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....